Table of Content




1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 17
1.2.1 INCLUSIONS & EXCLUSIONS 17
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 20
2.1.2 PRIMARY DATA 21
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION 21
2.1.4 DATA TRIANGULATION 22
2.2 MARKET ESTIMATION METHODOLOGY 22
2.3 MARKET GROWTH RATE PROJECTIONS 23
2.4 RESEARCH ASSUMPTIONS 25

3 EXECUTIVE SUMMARY 26

4 PREMIUM INSIGHTS 29
4.1 DRUG DISCOVERY INFORMATICS MARKET OVERVIEW 29
4.2 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET,
BY SOLUTION AND COUNTRY (2019) 29
4.3 DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION (USD MILLION) 30
4.4 DRUG DISCOVERY INFORMATICS MARKET SHARE, BY END USER, 2019 30

5 MARKET OVERVIEW 31
5.1 INTRODUCTION 31
5.2 MARKET DYNAMICS 31
5.2.1 DRIVERS 32
5.2.1.1 Increased research spending on informatics by the pharmaceutical and biotechnology industries 32
5.2.1.2 Growing demand and support for rare disease and orphan drug research 32
5.2.1.3 Focus on drug discovery using informatics software 32
?
5.2.2 RESTRAINTS 33
5.2.2.1 High setup costs of informatics software 33
5.2.3 OPPORTUNITIES 33
5.2.3.1 Patent expiry 33
5.2.3.2 Growing biotechnology industry and biologics market 33
5.2.3.3 Growth in emerging markets 33
5.2.4 CHALLENGE 34
5.2.4.1 Dearth of skilled professionals 34

6 DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 35
6.1 INTRODUCTION 36
6.2 SEQUENCING & TARGET DATA ANALYSIS 36
6.2.1 SEQUENCING & TARGET DATA ANALYSIS HOLDS LARGEST SHARE OF THE MARKET, BY FUNCTION 36
6.3 DOCKING 38
6.3.1 MOLECULAR DOCKING TARGETS THE DEVELOPMENT OF POTENTIAL MOLECULES 38
6.4 MOLECULAR MODELING 40
6.4.1 CAPABILITY TO GENERATE ESTIMATIONS OF DRUG POTENTIAL MAKE MODELING A PROMINENT TOOL 40
6.5 LIBRARY & DATABASE PREPARATION 41
6.5.1 INCREASE IN DRUG RESEARCH IS EXPANDING THE USE OF DRUG DATABASES 41
6.6 OTHER FUNCTIONS 43

7 DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 45
7.1 INTRODUCTION 46
7.2 DRUG DEVELOPMENT 46
7.2.1 PRECLINICAL TESTING 46
7.2.1.1 Growth in the number of preclinical testing activities to support market growth 46
7.2.2 CLINICAL TRIALS 47
7.2.2.1 Informatics software help assess important aspects about clinical trial success 47
7.3 DRUG DISCOVERY 48
7.3.1 INCREASED SPENDING ON DRUG DISCOVERY TO DRIVE MARKET GROWTH 48

8 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 51
8.1 INTRODUCTION 52
8.2 SOFTWARE 52
8.2.1 BENEFITS OF INFORMATICS SOFTWARE IN DRUG DISCOVERY ARE DRIVING THE GROWTH OF THE MARKET 52
8.3 SERVICES 54
8.3.1 A WIDE RANGE OF SERVICES IS AVAILABLE IN THE MARKET, FROM INSTALLATION TO POST-SALES SUPPORT 54

9 DRUG DISCOVERY INFORMATICS MARKET, BY END USER 56
9.1 INTRODUCTION 57
9.2 PHARMACEUTICAL COMPANIES 57
9.2.1 PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2018 57
9.3 BIOTECHNOLOGY COMPANIES 59
9.3.1 INCREASING DEMAND FOR PERSONALIZED MEDICINE TO BOOST THE USE OF INFORMATICS IN BIOTECHNOLOGY COMPANIES 59
9.4 CONTRACT RESEARCH ORGANIZATIONS 60
9.4.1 RISE IN OUTSOURCING TO DRIVE THE GROWTH OF THIS END-USER SEGMENT 60
9.5 OTHER END USERS 62

10 DRUG DISCOVERY INFORMATICS MARKET, BY REGION 64
10.1 INTRODUCTION 65
10.2 NORTH AMERICA 66
10.2.1 US 69
10.2.1.1 Rising R&D to support the growth of the drug discovery informatics market in the US 69
10.2.2 CANADA 71
10.2.2.1 Presence of a strong pharmaceuticals industry to propel market growth in Canada 71
10.3 EUROPE 73
10.3.1 UK 75
10.3.1.1 The UK is the largest market for drug discovery informatics in Europe 75
10.3.2 FRANCE 76
10.3.2.1 Loss of patent exclusivity of biologics to support the growth of the drug discovery informatics market in France 76
10.3.3 GERMANY 78
10.3.3.1 Increasing focus on drug discovery & development to drive market growth 78
10.3.4 ITALY 80
10.3.4.1 High production volume to boost drug informatics growth 80
10.3.5 SPAIN 81
10.3.5.1 Rising R&D expenditure to drive market growth in Spain 81
10.3.6 REST OF EUROPE 83
10.4 ASIA PACIFIC 85
10.4.1 CHINA 87
10.4.1.1 Large R&D pharmaceutical footprint to drive market growth in China 87
10.4.2 INDIA 89
10.4.2.1 Presence of a large number of CROs in India to propel market growth 89
10.4.3 JAPAN 91
10.4.3.1 Rising government initiatives for drug discovery to support the adoption of informatics software in Japan 91
10.4.4 REST OF ASIA PACIFIC 92
10.5 ROW 94
10.5.1 LATIN AMERICA IS AN ATTRACTIVE MARKET FOR DRUG DISCOVERY INFORMATICS IN THE ROW 94

11 COMPETITIVE LANDSCAPE 96
11.1 INTRODUCTION 96
11.2 MARKET RANKING ANALYSIS, 2018 96
11.3 COMPETITIVE LEADERSHIP MAPPING 97
11.3.1 VISIONARY LEADERS 97
11.3.2 DYNAMIC DIFFERENTIATORS 97
11.3.3 EMERGING COMPANIES 97
11.4 COMPETITIVE SCENARIO 99
11.4.1 KEY PRODUCT & SERVICE LAUNCHES 99
11.4.2 KEY ACQUISITIONS 99
11.4.3 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 100
11.4.4 KEY EXPANSIONS 100

12 COMPANY PROFILES 101
12.1 JUBILANT LIFE SCIENCES 101
12.2 CHARLES RIVER LABORATORIES INTERNATIONAL 103
12.3 IBM 105
12.4 CLARIVATE ANALYTICS 107
12.5 ACCENTURE 109
12.6 PERKINELMER 111
12.7 DASSAULT SYST?MES 113
12.8 EUROFINS SCIENTIFIC 115
12.9 EVOTEC AG 117
12.10 COGNIZANT 120
12.11 INFOSYS LIMITED 121
12.12 THERMO FISHER SCIENTIFIC 122
12.13 ALBANY MOLECULAR RESEARCH 124
12.14 SCHR?DINGER 125
12.15 SELVITA 127
12.16 CERTARA 128
12.17 GVK BIOSCIENCES 130
12.18 OPENEYE SCIENTIFIC SOFTWARE 131
12.19 IO INFORMATICS 132
12.20 CDD 133
*Details on Business Overview, Products/Servies Offered, Recent Developments, SWOT Analysis, and MnM View might not be captured in case of unlisted companies.

13 APPENDIX 134
13.1 DISCUSSION GUIDE 134
13.2 KNOWLEDGE STORE
13.3 AVAILABLE CUSTOMIZATIONS 139
13.4 RELATED REPORTS 139
13.5 AUTHOR DETAILS 140



List of Figures


FIGURE 1 BREAKDOWN OF PRIMARIES: DRUG DISCOVERY INFORMATICS MARKET 21
FIGURE 2 DATA TRIANGULATION METHODOLOGY 22
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (BOTTOM-UP APPROACH) 22
FIGURE 4 DRUG DISCOVERY INFORMATICS: MARKET SIZE (USD BILLION) 23
FIGURE 5 DRUG DISCOVERY INFORMATICS MARKET: CAGR PROJECTIONS 23
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS, OPPORTUNITIES, & CHALLENGES 24
FIGURE 7 DRUG DISCOVERY INFORMATICS MARKET SHARE & CAGR, BY FUNCTION 26
FIGURE 8 DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2019?2025 27
FIGURE 9 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2019 VS. 2025 (USD MILLION) 27
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE DRUG DISCOVERY INFORMATICS MARKET 28
FIGURE 11 RISING R&D EXPENDITURE IS THE PRIMARY GROWTH DRIVER FOR THE MARKET 29
FIGURE 12 SOFTWARE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE
NORTH AMERICAN DRUG DISCOVERY INFORMATICS MARKET IN 2019 29
FIGURE 13 SEQUENCING & TARGET DATA ANALYSIS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019 30
FIGURE 14 PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019 30
FIGURE 15 DRUG DISCOVERY INFORMATICS MARKET : MARKET DYNAMICS 31
FIGURE 16 DRUG DISCOVERY INFORMATICS MARKET, BY REGION, 2019 VS. 2024 65
FIGURE 17 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET SNAPSHOT 67
FIGURE 18 APAC: DRUG DISCOVERY INFORMATICS MARKET SNAPSHOT 85
FIGURE 19 RANK OF COMPANIES IN THE DRUG DISCOVERY INFORMATICS MARKET, 2018 96
FIGURE 20 DRUG DISCOVERY INFORMATICS MARKET (GLOBAL) COMPETITIVE
LEADERSHIP MAPPING, 2018 98
FIGURE 21 JUBILANT LIFE SCIENCES LIMITED: COMPANY SNAPSHOT (2019) 101
FIGURE 22 CHARLES RIVER: COMPANY SNAPSHOT (2018) 103
FIGURE 23 IBM: COMPANY SNAPSHOT (2018) 105
FIGURE 24 CLARIVATE ANALYTICS: COMPANY SNAPSHOT (2019) 107
FIGURE 25 ACCENTURE PLC: COMPANY SNAPSHOT : 2019 109
FIGURE 26 PERKINELMER: COMPANY SNAPSHOT (2018) 111
FIGURE 27 DASSAULT SYST?MES: COMPANY SNAPSHOT (2018) 113
FIGURE 28 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019) 115
FIGURE 29 EVOTEC: COMPANY SNAPSHOT (2018) 117
FIGURE 30 COGNIZANT: COMPANY SNAPSHOT (2019) 120
FIGURE 31 INFOSYS LIMITED: COMPANY SNAPSHOT (2019) 121
FIGURE 32 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT: 2018 122

 

List of Tables



TABLE 1 DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 36
TABLE 2 DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY REGION, 2017–2025 (USD MILLION) 37
TABLE 3 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY COUNTRY, 2017–2025 (USD MILLION) 37
TABLE 4 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY COUNTRY, 2017–2025 (USD MILLION) 37
TABLE 5 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY COUNTRY, 2017–2025 (USD MILLION) 38
TABLE 6 DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY REGION 2017–2025 (USD MILLION) 38
TABLE 7 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING BY COUNTRY, 2017–2025 (USD MILLION) 39
TABLE 8 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY COUNTRY, 2017–2025 (USD MILLION) 39
TABLE 9 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY COUNTRY, 2017–2025 (USD MILLION) 39
TABLE 10 DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELING BY REGION, 2017–2025 (USD MILLION) 40
TABLE 11 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELING, BY COUNTRY, 2017–2025 (USD MILLION) 40
TABLE 12 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELING, BY COUNTRY, 2017–2025 (USD MILLION) 41
TABLE 13 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELING BY COUNTRY, 2017–2025 (USD MILLION) 41
TABLE 14 DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY & DATABASE PREPARATION, BY REGION, 2017–2025 (USD MILLION) 42
TABLE 15 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY & DATABASE PREPARATION, BY COUNTRY, 2017–2025 (USD MILLION) 42
TABLE 16 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY & DATABASE PREPARATION, BY COUNTRY, 2017–2025 (USD MILLION) 42
TABLE 17 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY & DATABASE PREPARATION, BY COUNTRY, 2017–2025 (USD MILLION) 43
TABLE 18 DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS, BY REGION, 2017–2025 (USD MILLION) 43
TABLE 19 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS, BY COUNTRY, 2017–2025 (USD MILLION) 44
TABLE 20 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS BY COUNTRY, 2017–2025 (USD MILLION) 44
TABLE 21 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS BY COUNTRY, 2017–2025 (USD MILLION) 44
TABLE 22 DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 46
TABLE 23 DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY REGION, 2017–2025 (USD MILLION) 47
TABLE 24 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION) 47
TABLE 25 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION) 48
TABLE 26 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION) 48
TABLE 27 DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2017–2025 (USD MILLION) 49
TABLE 28 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION) 49
TABLE 29 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION) 49
TABLE 30 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION) 50
TABLE 31 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 52
TABLE 32 DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE, BY REGION 2017–2025 (USD MILLION) 53
TABLE 33 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE BY COUNTRY, 2017–2025 (USD MILLION) 53
TABLE 34 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE, BY COUNTRY, 2017–2025 (USD MILLION) 53
TABLE 35 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE, BY COUNTRY, 2017–2025 (USD MILLION) 54
TABLE 36 DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY REGION 2017–2025 (USD MILLION) 54
TABLE 37 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES BY COUNTRY, 2017–2025 (USD MILLION) 55
TABLE 38 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY COUNTRY, 2017–2025 (USD MILLION) 55
TABLE 39 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY COUNTRY, 2017–2025 (USD MILLION) 55
TABLE 40 DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 57
TABLE 41 DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES BY REGION, 2017–2025 (USD MILLION) 57
TABLE 42 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2025 (USD MILLION) 58
TABLE 43 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2025 (USD MILLION) 58
TABLE 44 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2025 (USD MILLION) 58
TABLE 45 DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES BY REGION, 2017–2025 (USD MILLION) 59
TABLE 46 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2025 (USD MILLION) 59
TABLE 47 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION) 60
TABLE 48 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2025 (USD MILLION) 60
TABLE 49 DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2017–2025 (USD MILLION) 61
TABLE 50 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2025 (USD MILLION) 61
TABLE 51 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2025 (USD MILLION) 61
TABLE 52 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2025 (USD MILLION) 62
TABLE 53 DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY REGION, 2017–2025 (USD MILLION) 62
TABLE 54 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2025 (USD MILLION) 63
TABLE 55 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS BY REGION, 2017–2025 (USD MILLION) 63
TABLE 56 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS BY COUNTRY, 2017–2025 (USD MILLION) 63
TABLE 57 DRUG DISCOVERY INFORMATICS MARKET, BY REGION 2017–2025 (USD MILLION) 66
TABLE 58 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY 2017–2025 (USD MILLION) 67
TABLE 59 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 68
TABLE 60 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 68
TABLE 61 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION) 68
TABLE 62 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 69
TABLE 63 US: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 69
TABLE 64 US: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 70
TABLE 65 US: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 70
TABLE 66 US: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 70
TABLE 67 CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 71
TABLE 68 CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 71
TABLE 69 CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 72
TABLE 70 CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 72
TABLE 71 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY 2017–2025 (USD MILLION) 73
TABLE 72 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 73
TABLE 73 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 74
TABLE 74 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 74
TABLE 75 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 74
TABLE 76 UK: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 75
TABLE 77 UK: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 75
TABLE 78 UK: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 76
TABLE 79 UK: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 76
TABLE 80 FRANCE: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 77
TABLE 81 FRANCE: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 77
TABLE 82 FRANCE: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 77
TABLE 83 FRANCE: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 78
TABLE 84 GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 78
TABLE 85 GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 79
TABLE 86 GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 79
TABLE 87 GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 79
TABLE 88 ITALY: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 80
TABLE 89 ITALY: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 80
TABLE 90 ITALY: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 81
TABLE 91 ITALY: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 81
TABLE 92 SPAIN: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 82
TABLE 93 SPAIN: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 82
TABLE 94 SPAIN: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 82
TABLE 95 SPAIN: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 83
TABLE 96 ROE: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 83
TABLE 97 ROE: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 84
TABLE 98 ROE: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 84
TABLE 99 ROE: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 84
TABLE 100 APAC: DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY 2017–2025 (USD MILLION) 86
TABLE 101 APAC: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 86
TABLE 102 APAC: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 86
TABLE 103 APAC: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 87
TABLE 104 APAC: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 87
TABLE 105 CHINA: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 88
TABLE 106 CHINA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 88
TABLE 107 CHINA: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 88
TABLE 108 CHINA: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 89
TABLE 109 INDIA: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 89
TABLE 110 INDIA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 90
TABLE 111 INDIA: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 90
TABLE 112 INDIA: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 90
TABLE 113 JAPAN: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 91
TABLE 114 JAPAN: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 91
TABLE 115 JAPAN: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 92
TABLE 116 JAPAN: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 92
TABLE 117 ROAPAC: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 93
TABLE 118 ROAPAC: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 93
TABLE 119 ROAPAC: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 93
TABLE 120 ROAPAC: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 94
TABLE 121 ROW: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 2017–2025 (USD MILLION) 94
TABLE 122 ROW: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 2017–2025 (USD MILLION) 95
TABLE 123 ROW: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION 2017–2025 (USD MILLION) 95
TABLE 124 ROW: DRUG DISCOVERY INFORMATICS MARKET, BY END USER 2017–2025 (USD MILLION) 95